Zenas BioPharma, Inc. Notes Assumed
Zenas BioPharma, Inc. (ZBIO) reported Notes Assumed of $21.15 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2026-03-16
- Zenas BioPharma, Inc. notes assumed for the quarter ending 2024-12-31 was $0.00.
- Zenas BioPharma, Inc. notes assumed for fiscal 2024 was $21.15M.
| Period end | Notes Assumed 3 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $21.15M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $21.15M 10-Q · filed 2024-11-12 |